Continuous Vital Sign Monitoring During Admission for Acute Exacerbations of Chronic Obstructive Pulmonary Disease - an Observational Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Obstructive Pulmonary Disease
- Sponsor
- University Hospital Bispebjerg and Frederiksberg
- Enrollment
- 200
- Locations
- 2
- Primary Endpoint
- Any serious adverse events
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
For patients admitted to the medical ward, it is often difficult to predict if their clinical condition will deteriorate, however subtle changes in vital signs are usually present 8 to 24 hours before a life-threatening event such as respiratory failure leading to ICU admission, or unanticipated cardiac arrest. Such adverse trends in clinical observations can be missed, misinterpreted or not appreciated as urgent. New continuous and wearable 24/7 clinical vital parameter monitoring systems offer a unique possibility to identify clinical deterioration before patients condition progress beyond the point-of-no-return, where adverse events are inevitable. The WARD-COPD project aims to determine the correlation between cardiopulmonary micro events and clinical adverse events during the first four days after hospital admission with acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
Investigators
Mikkel Elvekjaer
MD
University Hospital Bispebjerg and Frederiksberg
Eligibility Criteria
Inclusion Criteria
- •Adult patients admitted with AECOPD
- •Recruitment and monitoring start is possible within 24 hours after admission
Exclusion Criteria
- •Patient expected not to cooperate
- •Patient allergic to plaster, plastic or silicone
- •Active therapy withdrawn
- •Patients with dementia or not able to give informed consent
- •Patients with pacemaker or implantable cardioverter-defibrillator (ICD) unit
- •Expected discharge within less than 24 hours from possible inclusion
Outcomes
Primary Outcomes
Any serious adverse events
Time Frame: within 30 days after inclusion
E.g. cardiac arrest, ICU admission, acute myocardial infarction, stroke, sepsis, acute kidney injury or other serious adverse events (defined in Protocol Appendix A)
Secondary Outcomes
- Readmission(within 6 months after inclusion)
- Mortality(within 6 months after inclusion)